通过LIN28B介导的PI3K/AKT通路激活在结直肠癌模型中促进转移
Alice E Shin1, Kensuke Sugiura1, Secunda W Kariuki1
1Division of Digestive and Liver Diseases, Department of Medicine, and.
The Journal of clinical investigation
|January 14, 2025
概括
在结直肠癌 (CRC) 中过度表达的LIN28B通过PI3K/AKT通路驱动肝转移. 用像alpelisib这样的药物准这种途径为转移性CRC提供了治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症转移研究 癌症转移研究
背景情况:
- 结肠直肠癌 (CRC) 转移是癌症死亡的主要原因.
- 30%的CRC中LIN28B过度表达与转移有关,但机制尚不清楚.
- 对于PI3K路径突变的现有小鼠模型在瘤进展和转移方面存在局限性.
研究的目的:
- 为了阐明LIN28B在结直肠癌转移中的作用.
- 为了研究PI3K/AKT通路在LIN28B驱动的转移中的参与.
- 评估转移性结直肠癌的向治疗方法.
主要方法:
- 基因改造的CRC细胞系和过度表达LIN28B或活性Pik3ca的小鼠模型.
- 细胞迁移和侵入的体外试验;在小鼠体内转移的研究.
- 使用FDA批准的药物 (alpelisib,capivasertib) 和LY2584702在细胞系,有机体和患者衍生的有机体中进行垂直PI3K/AKT通路抑制的全面分析.
- 对患者样本进行组织微阵列分析.
主要成果:
- 在小鼠模型中,LIN28B过度表达增强了PI3K/AKT通路激活和肝转移.
- 使用alpelisib抑制PI3Kα可以减少CRC细胞的迁移,入侵和转移.
- LIN28B和PI3K/AKT通路的激活与患者组织中的CRC进展呈正相关性.
- 在临床前模型中,PI3K/AKT通路的垂直抑制显示出有前途.
结论:
- 通过PI3K/AKT通路,LIN28B对结直肠癌转移进行了关键调解.
- 针对PI3K/AKT通路的制是转移性CRC的可行的治疗策略.
- 来自患者的有机体是转移性CRC的精准医学中宝贵的工具.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.6K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.8K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
